Bio Essence Corporation
BIOE
$0.40
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3,828.62% | 101.08% | 127.77% | -253.70% | 85.75% |
| Total Depreciation and Amortization | -66.67% | 0.00% | -66.67% | -80.00% | 100.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.49% | -99.24% | -90.76% | 105.32% | -75.00% |
| Change in Net Operating Assets | -52.89% | -49.49% | -8.29% | 456.01% | 1,122.82% |
| Cash from Operations | 193.33% | -47.63% | 996.73% | 84.79% | 307.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 99.89% |
| Total Debt Issued | 140.48% | 73.26% | 1,561.82% | 81.44% | -193.72% |
| Total Debt Repaid | -889.72% | 18.78% | -82,600.00% | -3,212.37% | -468.15% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -181.24% | 53.03% | -2,793.10% | -85.61% | -254.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.35% | 41.38% | -100.00% | -- | -28,700.00% |